Oxford BioDynamics (LON:OBD) Share Price Crosses Below 50-Day Moving Average – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 0.15 and traded as low as GBX 0.12. Oxford BioDynamics shares last traded at GBX 0.13, with a volume of 35,299,465 shares traded.

Oxford BioDynamics Stock Performance

The firm’s 50-day simple moving average is GBX 0.15 and its 200-day simple moving average is GBX 0.21. The company has a quick ratio of 2.80, a current ratio of 2.01 and a debt-to-equity ratio of 131.61. The firm has a market capitalization of £5.15 million, a PE ratio of -0.60 and a beta of 0.42.

Oxford BioDynamics (LON:OBD) last announced its quarterly earnings data on Tuesday, June 30th. The biotechnology company reported GBX (0.10) earnings per share (EPS) for the quarter. Oxford BioDynamics had a negative net margin of 825.61% and a negative return on equity of 451.74%.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.